All living things emit a faint glow, scientists explore medical uses

On 28 July 2026, researchers reported that a faint glow emitted by all living organisms could be harnessed for non-invasive medical diagnostics and environmental monitoring. The study, published in Nature, details how this ultra-weak light—invisible to the naked eye—reflects cellular health.

The light, known as biophoton emission, stems from metabolic processes involving reactive oxygen species and other excited molecules. Scientists detected these biophotons from humans, plants, and microbes using highly sensitive photon counters.

Emission intensity varies with stress, disease, and environmental conditions. Cancer cells, for example, produce a biophoton signature distinct from healthy cells, while stressed plants show altered light patterns. The researchers observed that oxidative stress raises photon emission, and antioxidants reduce it.

This non-invasive signal could replace invasive procedures and destructive sampling, allowing continuous monitoring of cellular states. The work may transform oncology, agriculture, and ecology by delivering immediate feedback on biological activity.

The team measured emissions as low as a few photons per second per square centimeter. They also built a portable detector prototype for field use, setting the stage for practical applications.

Future efforts aim to refine the technology for clinical trials, including a handheld device for early cancer detection. Sensors deployed in farmlands might monitor crop health in real time, potentially cutting chemical inputs. More research is needed to standardize measurements and distinguish normal from pathological signals, the researchers caution.